Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Director dealings: Atome chairman raises stake

(Sharecast News) - Atome revealed on Thursday that chairman Peter Levine had acquired 4.75m ordinary shares in the AIM-listed advanced fertiliser developer. Levine, the single largest Atome shareholder, purchased the shares at an average price of 60p each, for a total value of £2.85m.

Following the transaction, Levine holds a beneficial interest in 19.51m ordinry Atome shares, representing approximately 26.04% of the company's issued share capital.

As of 1555 BST, Atome shares were down 0.09% at 60.94p.

Reporting by Iain Gilbert at Sharecast.com

Top Director Buys

Atome (ATOM) Director name: Levine,Peter M Amount purchased: 4,753,086 @ 60.00p Value: £2,851,851.71

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount purchased: 76,298 @ 267.00p Value: £203,715.67

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount purchased: 62,184 @ 267.00p Value: £166,031.28

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount purchased: 61,575 @ 267.00p Value: £164,405.25

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount purchased: 61,575 @ 267.00p Value: £164,405.25

Atome (ATOM) Director name: Levine,Nikita Petrovich Amount purchased: 246,914 @ 60.00p Value: £148,148.41

Atome (ATOM) Director name: (Hellmers),James E C Spalding Amount purchased: 198,347 @ 60.00p Value: £119,008.20

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount purchased: 43,258 @ 267.00p Value: £115,498.86

Atome (ATOM) Director name: Mussat,Olivier Charles Frederic Amount purchased: 123,457 @ 60.00p Value: £74,074.20

Atome (ATOM) Director name: Valladares,Mary-Rose de Amount purchased: 101,277 @ 60.00p Value: £60,766.20

Atome (ATOM) Director name: Sheffrin,Robert Anthony Amount purchased: 57,482 @ 60.00p Value: £34,489.20

Yougov (YOU) Director name: Martin,Ashley G Amount purchased: 8,051 @ 186.00p Value: £14,974.86

Yougov (YOU) Director name: Mishra,Devesh Amount purchased: 8,051 @ 186.00p Value: £14,974.86

Yougov (YOU) Director name: Newman,Andrea Amount purchased: 2,683 @ 186.00p Value: £4,990.38

Top Director Sells

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount sold: 215,041 @ 267.00p Value: £574,159.49

Liontrust Asset Management (LIO) Director name: Ions,John Stephen Amount sold: 89,849 @ 267.00p Value: £239,896.84

Share this article

Related Sharecast Articles

Director dealings: British American Tobacco's Karen Guerra purchases shares
(Sharecast News) - British American Tobacco revealed on Thursday that non-executive director Karen Guerra had acquired 6,000 ordinary shares in the FTSE 100-listed tobacco giant.
Director dealings: Convatec non-executive director makes share purchase
(Sharecast News) - Convatec revealed on Wednesday that non-executive director Jens Viebke had acquired 24,400 ordinary shares in the FTSE 100-listed medical products and technology firm.
Director dealings: Mortgage Advice Bureau chairman snaps up shares
(Sharecast News) - Mortgage Advice Bureau revealed on Tuesday that non-executive chairman Michael Jones had acquired 5,833 ordinary shares in the AIM-listed property finance platform operator.
Director dealings: Insig Ai CEO raises stake
(Sharecast News) - Insig Ai revealed on Monday at chief executive Richard Bernstein had acquired 400,000 ordinary shares in the AIM-listed data infrastructure and machine learning firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.